The majority of published human anti-insulin BCR sequences were isolated from people with established T1D (Stage 4 T1D) who were on insulin therapy, which is known to elicit a “foreign” anti-insulin antibody response to exogenous insulin administration, even in people who were previously insulin autoantibody negative.26–30. The gene discussed is BCR; the disease is type 1 diabetes mellitus.